Trial Profile
Ensayo clinico fase II con cetuximab bisemanal en combinacion con oxaliplatino, 5-fluorouracilo y acido folinico (folfox-4) en el tratamiento de primera linea del cancer colorectal metastasico kras tipo natural
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 Oct 2015
Price :
$35
*
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil; Folinic acid; Oxaliplatin
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms OPTIMIX-ACROSS
- 23 Aug 2011 New trial record